Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America (Volume 44-4) (The Clinics: Internal Medicine, Volume 44-4) - Image 1

£55.00

Elsevier Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America (Volume 44-4) (The Clinics: Internal Medicine, Volume 44-4)

Name: Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America (Volume 44-4) (The Clinics: Internal Medicine, Volume 44-4)
Brand: Elsevier
Price: 55.0 GBP
Availability: InStock

Diseases & Disorders

It has never been this cheap. We have no record of a lower price.

£55 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £55 (52 days, 69.3%)

Price range: £55 - £56

Price levels: 2 different prices over 75 days

Description

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

Product Specifications

Brand: Elsevier
Format: hardcover
ASIN: 0323402488
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders
Domain: Amazon UK
Release Date: 28 December 2015
Listed Since: 05 June 2015

Barcode

No barcode data available

Elsevier Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America (Volume 44-4) (The Clinics: Internal Medicine, Volume 44-4)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Hepatitis C Virus and Liver Transplantation

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Hepatitis B Virus, An Issue of Clinics in Liver Disease (Volume 23-2) (The Clinics: Internal Medicine, Volume 23-2)

Hepatitis B Virus and Liver Disease

Hepadnaviruses: Molecular Biology and Pathogenesis: 168 (Current Topics in Microbiology and Immunology, 168)

Complications of Cirrhosis, An Issue of Clinics in Liver Disease (Volume 31-1) (The Clinics: Internal Medicine, Volume 31-1)

HIV and Liver Disease

Management of Helicobacter pylori-Related Diseases, An Issue of Gastroenterology Clinics of North America (Volume 44-3) (The Clinics: Internal Medicine, Volume 44-3)

Exploring the messy realities of living with Hepatitis C

Hepatitis Prevention and Treatment (Milestones in Drug Therapy)

Hepatic Encephalopathy, An Issue of Clinics in Liver Disease (Volume 24-2) (The Clinics: Internal Medicine, Volume 24-2)

Chronic Hepatitis: Metabolic, Cholestatic, Viral and Autoimmune: 157 (Falk Symposium, 157)

Molecular Components of Hepatitis B Virus: 6 (Developments in Molecular Virology, 6)

Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma

Hepatitis Delta Virus: 307 (Current Topics in Microbiology and Immunology, 307)

Liver Cirrhosis: Causes, Diagnosis & Treatment (Hepatology Research and Clinical Developments)

Treatment strategies of HCV patients in different medical conditions

The Equine Liver, An Issue of Veterinary Clinics of North America: Equine Practice: Volume 42-2 (The Clinics: Veterinary Medicine, Volume 42-2)

Liver Cirrhosis: From Pathophysiology to Disease Management: 162 (Falk Symposium, 162)

Technical Aspects of Oncological Hepatic Surgery, An Issue of Surgical Clinics of North America (Volume 96-2) (The Clinics: Surgery, Volume 96-2)

Effects of Fluoroquinolones on the Helicase Activity of HCV

Infectious Agents and Cancer

Medical Virology 10: 10th (Medical Virology: International Symposium Proceedings)

Gastrointestinal Transplantation, An Issue of Gastroenterology Clinics of North America (Volume 47-2) (The Clinics: Internal Medicine, Volume 47-2)